Objective:
Help small and medium Biotechnology & Innovative businesses add value to and effectively partner in life sciences and healthcare
BACKGROUND & IMPACT
Began my career as an Oncology scientist, helping innovative firms and ideas gain commercial success.
Integrated Digital AI for growth & resource optimization.
WORK EXPERIENCE
2016-2023
Built Data Sciences R&D function contributing to 20 new drug approvals over 3 years
2017-2019
Executive in Residence: Guest lecturer, Business & Economics of Healthcare, Healthcare Conference panelist
2019-2023
Developed ready for proof-of-concept gaming product for pediatric compliance in Diabetes ad Obesity
2013-2016
Established global precision medicine function to enhance commercial input into early R&D . Led early commercial Oncology go / no go decisions
2011-2023
Led companion diagnostics pipeline portfolio and drove lung cancer product launches with Genentech and Pfizer
2001-2011
Led patient segment launch strategy for a $300MUSD HEM/ONC injectable, contributing to 2-fold increase in market share in 18 months. Evaluated products for global business development
PUBLIC SPEAKING & PROFESSIONAL ENGAGEMENTS
-
Stern School of Business, Guest lecturer, Business & Economics of Healthcare Career coach, Management Consulting Association Conference
-
Rutgers School of Business, Lecturer, Personalized Medicine & Bio pharmaceuticals
BOARD MEMBER & CONFERENCE SPEAKER
-
Womensphere Foundation & NY Women in STEM 2008–Present | Board member, speaker, & mentor
-
NYU Stern School of Business, Precision medicine panelist, Healthcare Association
-
World CDx, Speaker & co-host, World Personalized Medicine
AWARDS & ACCOMPLISHMENTS
-
J&J Strategic Counsel & Leadership Award, Government Affairs & Policy
-
J&J Global Commercial Encore Award, Digital Health White Paper
-
Lung Cancer Institute at J&J, Encore Award, Strategic Prioritization and Lung Cancer Quality Measure
-
Bayer HealthCare PINNACLE Award, Precision Medicine Portfolio Management
-
Bayer HealthCare Commercial Excellence Award, team performance in Launch and Revenue growth, 2008
